Avid Bioservices Inc (CDMO)

[biopharm]

CJ, Biomarkers are the most important factor at this stage...as without Biomarkers based on PS Targeting...some can not gain fast ...very fast ..FDA approvals

I am only taking a small portion of a post that should be ready slowly...but all should see the Perkin Elmer ties ...actually 3 of them, well more if one includes Frank Witney now...our Ampersand Capital sidekick to Mark Bamforth and Patrick Walsh ...

Things will continue to become I increasingly, interesting around here ..

...
#4 6/3/17 ASCO’17 #11603 (Session: Tumor Biology)
“Preliminary Correlative Analysis of PD-L1 Expression from the Sunrise Study”
http://abstracts.asco.org/199/AbstView_199_190902.html
AUTHORS:
LEAD: Nikoletta Lea Kallinteris (PPHM)
Rachel E. Sanborn (Co-Dir., Thoracic Oncology Pgm, Robert W. Franz Cancer Res. Center, Earle A. Chiles Res. Inst., Providence CC, Portland; Honoraria=AstraZeneca; Consulting=Amgen/Ariad/DNA/PPHM/SeaGen; Funding=BMS/MedImmune/Merck)
Leora Horn (Oncologist/Vanderbilt-Ingram CC; Honoraria=Biodesix; Funding=AZN)
David E. Gerber (UTSW)
Ronald B. Natale (Med.Dir/Lung-Cancer-Pgm/Cedars-Sinai Medical Center; consult/funding=AstraZeneca)
Min Tang (PPHM)
Sean Downing (Scientist/Molecular Pathology, Foundation Medicine Inc., Cambridge MA) http://www.foundationmedicine.com ; disclosure=PerkinElmer)
Amanda Clement (Scientist/PerkinElmer; disclosure=Abbvie)
Tobias Guennel (Sen.Dir., Translational Informatics & Biometrics, Precision for Medicine, Frederick MD https://www.precisionmedicinegrp.com/pfm )
Joseph Shan (PPHM, VP/Clin+Reg)
SENIOR AUTHOR: Cliff Hoyt (Oncology Fellow/PerkinElmer)

I am sure some will figure it out sooner or later ....but I guess Ampersand can always just make a big splash announcement with Bio Rad ( has a subsidiary MorphoSys US ties to same MorphoSys that lost patent war to JnJ recently for MM ) and maybe Alice Schwartz ( Bio Rad Billionaire that buys Bavituximab ...hmmm) will put everyone in their place and she can just throw a twist into all this for all the greed that continues


_________

Frank Witney


July 22, 2016

Frank Witney BOD Perkin Elmer

http://ir.perkinelmer.com/news-releases/news-release-details/perkinelmer-elects-frank-witney-board-directors

_______________

Sept 6, 2016
Frank Witney Sep 5, 2016 details on deals and he knows the value of PS Targeting / diagnostics etc

https://cen.acs.org/articles/94/i35/CEN-Talks-Frank-Witney-executive.html

____________

Sept 19, 2016

Frank Witney into Ampersand Capital

http://ampersandcapital.com/wp-content/uploads/2016/09/Frank-Witney-Joins-Ampersand-as-Operating-Partner-9-19-16.pdf

____

Mr Bamforth, you can call Frank Witney now and maybe realize ...investigations are active and one whistleblower is not much to ask for when things are so obvious ...unless again, it was part of some plan... (though then we got John Stafford who just so happened to fell into this to allow things to happen ...kind of in a bind)

A "Rare Site" into how things go down does not happen very often...and so much more but Nantucket is a busy time of year at this time

_____